Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,210 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $241.09 | 11 | $0 (2019) |
| Lilly USA, LLC | $169.16 | 7 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $141.33 | 9 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $89.97 | 5 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $88.71 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $84.31 | 5 | $0 (2019) |
| PFIZER INC. | $74.55 | 5 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $69.35 | 5 | $0 (2019) |
| Astellas Pharma US Inc | $57.16 | 3 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $35.04 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $270.81 | 19 | Merck Sharp & Dohme Corporation ($48.60) |
| 2018 | $332.06 | 24 | Janssen Pharmaceuticals, Inc ($67.23) |
| 2017 | $606.77 | 31 | GlaxoSmithKline, LLC. ($145.18) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/25/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DIABETES | ||||||
| 06/07/2019 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: VACCINE | ||||||
| 06/04/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Neuroscience | ||||||
| 05/22/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: DIABETES | ||||||
| 05/11/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/30/2019 | Merck Sharp & Dohme Corporation | STEGLATRO (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/09/2019 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/04/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/01/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: RESPIRATORY | ||||||
| 02/20/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: RESPIRATORY | ||||||
| 02/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: DIABETES | ||||||
| 02/08/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/05/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: UROLOGY | ||||||
| 01/29/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2019 | Vanda Pharmaceuticals Inc. | Hetlioz (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: Non-24-Hour Sleep-Wake Disorder | ||||||
| 12/14/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: VACCINES | ||||||
| 11/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DIABETES | ||||||
| 10/26/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 515 | 659 | $251,778 | $62,535 |
| 2022 | 6 | 510 | 605 | $207,091 | $50,101 |
| 2021 | 7 | 446 | 514 | $163,686 | $43,463 |
| 2020 | 9 | 604 | 819 | $145,077 | $43,586 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 264 | $103,515 | $21,280 | 20.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $61,175 | $19,144 | 31.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $27,550 | $8,741 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 136 | $35,360 | $8,232 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $11,800 | $2,214 | 18.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $11,566 | $2,180 | 18.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $812.00 | $744.73 | 91.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 206 | 266 | $101,178 | $22,278 | 22.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 112 | 112 | $42,757 | $14,097 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 169 | $43,244 | $9,877 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 25 | $12,805 | $2,864 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $4,235 | $797.39 | 18.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $2,872 | $187.85 | 6.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 185 | 239 | $88,363 | $22,047 | 25.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 143 | 154 | $38,444 | $9,895 | 25.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $17,765 | $6,132 | 34.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 29 | 32 | $16,040 | $4,333 | 27.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $696.00 | $696.00 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 17 | 17 | $2,210 | $192.10 | 8.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 12 | 12 | $168.00 | $168.00 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 226 | 300 | $71,056 | $19,642 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 148 | 148 | $36,571 | $16,745 | 45.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 128 | 146 | $23,277 | $5,308 | 22.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 16 | 77 | $6,860 | $668.58 | 9.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 21 | 22 | $2,129 | $562.45 | 26.4% |
About Dr. Michael Schneider, MD
Dr. Michael Schneider, MD is a Internal Medicine healthcare provider based in Brookfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477520443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Schneider, MD has received a total of $1,210 in payments from pharmaceutical and medical device companies, with $270.81 received in 2019. These payments were reported across 74 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,210).
As a Medicare-enrolled provider, Schneider has provided services to 2,075 Medicare beneficiaries, totaling 2,597 services with total Medicare billing of $199,685. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Brookfield, WI
- Active Since 03/08/2006
- Last Updated 07/12/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477520443
Products in Payments
- XARELTO (Drug) $141.33
- TRULICITY (Drug) $132.05
- SHINGRIX (Drug) $125.00
- XIFAXAN (Drug) $69.35
- TRADJENTA (Drug) $59.59
- TRELEGY ELLIPTA (Drug) $59.27
- PRALUENT (Drug) $51.80
- Myrbetriq (Drug) $38.28
- SOLIQUA (Drug) $38.17
- JARDIANCE (Drug) $37.11
- CHANTIX (Drug) $31.20
- VIAGRA (Drug) $28.28
- Hetlioz (Drug) $25.75
- PNEUMOVAX 23 (Biological) $25.26
- JANUVIA (Drug) $24.77
- STIOLTO RESPIMAT (Drug) $24.72
- Livalo (Drug) $24.45
- BYSTOLIC (Drug) $19.15
- MYRBETRIQ (Drug) $18.88
- ANORO (Drug) $18.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brookfield
Dr. Mushir Hassan, Md, MD
Internal Medicine — Payments: $7,415
Ehtesham Ghani, Md, MD
Internal Medicine — Payments: $4,653
Dr. Thomas Johnson, Md, MD
Internal Medicine — Payments: $3,260
Jessica Olson, Apnp, APNP
Internal Medicine — Payments: $3,254
Dr. Russell Blankenburg, Md, MD
Internal Medicine — Payments: $3,219
Dr. Gregory Spielbauer, Md, MD
Internal Medicine — Payments: $2,420